Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Comparative growth of different rotavirus strains in differentiated cells (MA104, HepG2, and CaCo-2).
Abstract: The production of viral antigen after infection of MA104, HepG2 (derived from human liver), and CaCo-2 (derived from human colon) cells with various cultivatable human and animal rotavirus strains was compared using immunofluorescence tests. All rotavirus strains examined expressed antigen in CaCo-2 cells and MA104 cells, but only some virus strains, namely, SA11-Cl3 (simian), RRV (simian), CU-1 (canine), and Ty1 (turkey), produced antigen in numbers of infected HepG2 cells comparable to infections in MA104 and CaCo-2 cells. Fl-14 (equine), OSU (porcine), NCDV (bovine), and Ch2 (chicken) strains were found to infect moderate numbers of HepG2 cells. Most human rotaviruses (representing viruses in serotypes 1, 2, 3, 4, 8, and 9), a simian rotavirus variant (SA11-4F), lapine (Ala, C-11 and R-2) viruses and porcine (Gottfried) virus infections resulted either in no detectable antigen or antigen synthesis in a low percentage of HepG2 cells. Human rotavirus isolates obtained from the stool specimens of an immunocompromised child with rotavirus antigen in his liver showed two different patterns of replication in HepG2 cells. Examination of the replication of a subset of viruses in the liver and intestinal tissues of orally infected suckling mice showed the CU-1 and Ty1 strains replicated well, while the OSU and human rotavirus strains did not. These results indicate that growth restriction in HepG2 cells is not serotype-specific, and growth of a virus in HepG2 cells does not necessarily correlate with the hepatotropic potential of a virus strain. Factors that may influence these differences of virus infectivity in HepG2 cells are discussed.
Publication Date: 1991-10-01 PubMed ID: 1653495DOI: 10.1016/0042-6822(91)90443-fGoogle Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Comparative Study
- Journal Article
- Research Support
- U.S. Gov't
- P.H.S.
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates the growth of various human and animal rotavirus strains in three types of cells: MA104, HepG2 (human liver cells), and CaCo-2 (human colon cells). The paper suggests no clear correlation between a virus’s growth in HepG2 cells and its potential to infect the liver.
Research Methodology and Objectives
- The aim of the study was to compare the production of viral antigen, a substance that creates an immune response, in different cells (MA104, HepG2, and CaCo-2) when infected by different rotavirus strains.
- The rotavirus strains chosen for the study included strains from various animals (including simians, canines, turkeys, horses, pigs, cows, and chickens) and humans. The human rotavirus strains represented serotypes 1,2,3,4,8 and 9.
- The viral antigens were detected and measured using immunofluorescence tests, a laboratory technique used to identify the presence and distribution of specific proteins.
Key Findings
- The researchers discovered that all rotavirus strains examined were capable of expressing antigen in both CaCo-2 cells and MA104 cells.
- However, when it comes to HepG2 cells, only some rotavirus strains such as SA11-Cl3 (simian strain), RRV (simian strain), CU-1 (canine), and Ty1 (turkey) were found to produce antigen in significant amounts.
- Conversely, most human rotaviruses, a simian rotavirus variant (SA11-4F), lapine (Ala, C-11 and R-2) viruses, and porcine (Gottfried) virus infections resulted in either no detectable antigen or a low level of antigen synthesis in HepG2 cells.
- The growth restriction seen in HepG2 cells was not found to be serotype-specific, and the ability of a virus to grow in HepG2 cells did not necessarily suggest that the virus strain has a strong potential to infect the liver (hepatotropic potential).
Implications and Further Discussion
- This research is significant as it sheds light on the variability of rotavirus growth in different cell environments. The study demonstrates that not all strains behave the same way in all types of cells. Hence, understanding the cell-specific response to rotavirus infection can help in the development of effective therapies.
- The factors influencing the differences in virus infectivity in HepG2 cells may require further research to fully understand the infection and transmission patterns of different rotavirus strains, which could further aid in developing effective preventions and treatments.
Cite This Article
APA
Kitamoto N, Ramig RF, Matson DO, Estes MK.
(1991).
Comparative growth of different rotavirus strains in differentiated cells (MA104, HepG2, and CaCo-2).
Virology, 184(2), 729-737.
https://doi.org/10.1016/0042-6822(91)90443-f Publication
Researcher Affiliations
- Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030.
MeSH Terms
- Animals
- Antigens, Viral / analysis
- Cell Differentiation
- Cells, Cultured
- Diarrhea / microbiology
- Haplorhini
- Humans
- In Vitro Techniques
- Intestines / microbiology
- Kidney / microbiology
- Liver / microbiology
- Mice
- Rotavirus / growth & development
- Rotavirus / immunology
- Virus Replication
Grant Funding
- AI 20649 / NIAID NIH HHS
- AI16687 / NIAID NIH HHS
- DK 30144 / NIDDK NIH HHS
Citations
This article has been cited 25 times.- Kawagishi T, Sánchez-Tacuba L, Feng N, Costantini VP, Tan M, Jiang X, Green KY, Vinjé J, Ding S, Greenberg HB. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proc Natl Acad Sci U S A 2023 Feb 28;120(9):e2214421120.
- Santos-Ferreira N, Van Dycke J, Neyts J, Rocha-Pereira J. Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. Microorganisms 2021 Jul 27;9(8).
- Roodsant T, Navis M, Aknouch I, Renes IB, van Elburg RM, Pajkrt D, Wolthers KC, Schultsz C, van der Ark KCH, Sridhar A, Muncan V. A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine. Front Cell Infect Microbiol 2020;10:272.
- Feng N, Hu L, Ding S, Sanyal M, Zhao B, Sankaran B, Ramani S, McNeal M, Yasukawa LL, Song Y, Prasad BVV, Greenberg HB. Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells. J Clin Invest 2019 Aug 12;129(9):3839-3851.
- Hong KJ, Seo SH. Organoid as a culture system for viral vaccine strains. Clin Exp Vaccine Res 2018 Jul;7(2):145-148.
- Saxena K, Simon LM, Zeng XL, Blutt SE, Crawford SE, Sastri NP, Karandikar UC, Ajami NJ, Zachos NC, Kovbasnjuk O, Donowitz M, Conner ME, Shaw CA, Estes MK. A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A 2017 Jan 24;114(4):E570-E579.
- Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Donowitz M, Estes MK. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol 2016 Jan 1;90(1):43-56.
- Ball JM, Medina-Bolivar F, Defrates K, Hambleton E, Hurlburt ME, Fang L, Yang T, Nopo-Olazabal L, Atwill RL, Ghai P, Parr RD. Investigation of Stilbenoids as Potential Therapeutic Agents for Rotavirus Gastroenteritis. Adv Virol 2015;2015:293524.
- Gibbons TF, Storey SM, Williams CV, McIntosh A, Mitchel DM, Parr RD, Schroeder ME, Schroeder F, Ball JM. Rotavirus NSP4: Cell type-dependent transport kinetics to the exofacial plasma membrane and release from intact infected cells. Virol J 2011 Jun 6;8:278.
- Halasz P, Holloway G, Turner SJ, Coulson BS. Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield. J Virol 2008 Jan;82(1):148-60.
- Cuadras MA, Bordier BB, Zambrano JL, Ludert JE, Greenberg HB. Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J Virol 2006 Apr;80(8):3935-46.
- Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004 Oct;78(19):10213-20.
- Mohan KV, Kulkarni S, Glass RI, Zhisheng B, Atreya CD. A human vaccine strain of lamb rotavirus (Chinese) NSP4 gene: complete nucleotide sequence and phylogenetic analyses. Virus Genes 2003;26(2):185-92.
- Coulson BS, Witterick PD, Tan Y, Hewish MJ, Mountford JN, Harrison LC, Honeyman MC. Growth of rotaviruses in primary pancreatic cells. J Virol 2002 Sep;76(18):9537-44.
- Cuadras MA, Feigelstock DA, An S, Greenberg HB. Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol 2002 May;76(9):4467-82.
- Ciarlet M, Crawford SE, Cheng E, Blutt SE, Rice DA, Bergelson JM, Estes MK. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol 2002 Feb;76(3):1109-23.
- Ciarlet M, Crawford SE, Estes MK. Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol 2001 Dec;75(23):11834-50.
- Brunet JP, Jourdan N, Cotte-Laffitte J, Linxe C, Géniteau-Legendre M, Servin A, Quéro AM. Rotavirus infection induces cytoskeleton disorganization in human intestinal epithelial cells: implication of an increase in intracellular calcium concentration. J Virol 2000 Nov;74(22):10801-6.
- Macartney KK, Baumgart DC, Carding SR, Brubaker JO, Offit PA. Primary murine small intestinal epithelial cells, maintained in long-term culture, are susceptible to rotavirus infection. J Virol 2000 Jun;74(12):5597-603.
- Abad FX, Pintó RM, Bosch A. Flow cytometry detection of infectious rotaviruses in environmental and clinical samples. Appl Environ Microbiol 1998 Jul;64(7):2392-6.
- Jourdan N, Maurice M, Delautier D, Quero AM, Servin AL, Trugnan G. Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol 1997 Nov;71(11):8268-78.
- Coulson BS, Londrigan SL, Lee DJ. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A 1997 May 13;94(10):5389-94.
- Kitamoto N, Mattion NM, Estes MK. Alterations in the sequence of the gene 4 from a human rotavirus after multiple passages in HepG2 liver cells. Arch Virol 1993;130(1-2):179-85.
- Raj P, Matson DO, Coulson BS, Bishop RF, Taniguchi K, Urasawa S, Greenberg HB, Estes MK. Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol 1992 Mar;30(3):704-11.
- Kotaki T, Kanai Y, Onishi M, Sakai Y, Motooka D, Chen Z, Enoki Y, Komatsu S, Hirai K, Minami S, Kawagishi T, Ushijima H, Kobayashi T. Single-round infectious rotaviruses with deletions of VP7 or VP4 genes, based on SA11 and WC3 strain backbones, and their potential use as viral vectors. PLoS Pathog 2025 Sep;21(9):e1013484.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
